Export

Lisinopril + amlodipine
Essential medicine status
Section:
12. Cardiovascular medicines 12.3. Antihypertensive medicines
ATC codes: C09BB03
Indication
Essential hypertension ICD11 code: BA00.Z
INN
Lisinopril + amlodipine
Medicine type
Chemical agent
List type
Core
Formulations
Oral > Solid: 10 mg + 5 mg ; 20 mg + 5 mg ; 20 mg + 10 mg
EML status history
First added in 2019 (TRS 1021)
Changed in 2021 (TRS 1035)
Sex
All
Age
Adolescents and adults
Therapeutic alternatives
Medicines within the same pharmacological class can be used
Therapeutic alternatives limitations
Therapeutic alternatives are medicines in the 4th level ATC chemical subgroups: C09AA ACE inhibitors, plain (for lisinopril) and C08CA Dihydropyridine derivatives (for amlodipine)
Patent information
Patents have expired in most jurisdictions
Wikipedia
Lisinopril + amlodipine
DrugBank
Lisinopril ,
Amlodipine
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended that fixed-dose combinations of medicines in 4th level ATC chemical subgroups, C09AA ACE inhibitors, plain (for lisinopril) and C08CA Dihydropyridine derivatives (for amlodipine), be specified as therapeutic alternatives under the square box listing for lisinopril + amlodipine on the EML.